Skip to main content

New Products: Affymetrix and BioDiscovery's Nexus for OncoScan Software

Premium

Affymetrix and BioDiscovery this week announced the availability of Nexus for OncoScan Software for the analysis of whole-genome copy number data generated from formalin-fixed, paraffin-embedded solid tumor samples using Affy's OncoScan FFPE Express 2.0 Service.

The offering is based on BioDiscovery's Nexus Copy Number software. The two companies said they intend to launch an updated version of the Nexus for OncoScan Software when Affy rolls out a kitted version of the assay later this year.

Using Affy's OncoScan service, customers can currently analyze highly degraded DNA in FFPE tumor samples. The company claimed that 30 cancer research institutes, including MD Anderson Cancer Center; the University of California, San Francisco; and the Huntsman Cancer Institute at the University of Utah, have all used the service.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.